- 17071-62-41,3-Adamantanediol
- 170727-02-32-Thiophenesulfonylchloride, 3-bromo-
- 170729-79-0Morpholine,2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, [2R-[2a(S*),3a]]- (9CI)
- 170729-80-3Aprepitant
- 170730-06-0Ethanone,1-(2,3-dihydro-7-benzofuranyl)-
- 170735-25-8Benzenecarboximidamide, 3-chloro-4-methyl-
- 170737-46-96-Bromo-2-Naphthalenecarboxaldehyde
- 170737-53-81-N-Cbz-4-Methoxycarbonylmethyl-piperidine
- 170737-93-6(2-Chloro-4-methoxyphenyl)acetonitrile
- 170744-18-0Hydroxyethyl Beta-Cyclodextrin
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
3-Methyl-2-phenylmorpholine hydrochloride |
EINECS | N/A |
| CAS No. | 1707-14-8 | Density | g/cm3 |
| PSA | 21.26000 | LogP | 2.86680 |
| Solubility | N/A | Melting Point |
175-177°C |
| Formula | C11H15 N O . Cl H | Boiling Point | 285.2°Cat760mmHg |
| Molecular Weight | 213.707 | Flash Point | 112.7°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. Human reproductive effects. Human teratogenic effects by ingestion: developmental abnormalities of the respiratory and gastrointestinal systems, and effects on newborn including neonatal measures or effects. When heated to decomposition it emits very toxic fumes of NOx and HCl. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Morpholine,3-methyl-2-phenyl-, hydrochloride (6CI,8CI,9CI);2-Phenyl-3-methyltetrahydro-1,4-oxazine hydrochloride;3-Methyl-2-phenylmorpholine hydrochloride; Marsine; Mefolin; Neo-Zine;Phenmetrazine hydrochloride; Preludin; Preludin hydrochloride |
Article Data | 3 |
3-Methyl-2-phenylmorpholine hydrochloride Chemical Properties
IUPAC Name: 3-methyl-2-phenylmorpholine hydrochloride
Synonyms of 3-Methyl-2-phenylmorpholine hydrochloride (CAS NO.1707-14-8): Phenmetrazine Hydrochloride [USAN] ; 2-Phenyl-3-methyltetrahydro-1,4-oxazine hydrochloride ; 3-Methyl-2-phenyltetrahydro-2H-1,4-oxazine hydrochloride ; A 66 hydrochloride ; EINECS 216-950-6 ; Marsin ; Mefolin ; NSC 405728 ; Neo-zine ; Phenmetrazine hydrochloride ; Preludin ; Probese-P hydrochloride ; Psychamine A 66 hydrochloride ; UNII-6U85YRT588 ; USAF GE-1 ; Morpholine, 3-methyl-2-phenyl-, hydrochloride ; DEA No. 1631 ; Preludin
CAS NO: 1707-14-8
Molecular Formula of 3-Methyl-2-phenylmorpholine hydrochloride (CAS NO.1707-14-8): C11H16ClNO
Molecular Weight: 213.7038
Molecular Structure:
.png)
H bond acceptors: 2
H bond donors: 1
Freely Rotating Bonds: 1
Polar Surface Area: 12.47 Å2
Flash Point of 3-Methyl-2-phenylmorpholine hydrochloride (CAS NO.1707-14-8): 112.7 °C
Enthalpy of Vaporization: 52.43 kJ/mol
Boiling Point: 285.2 °C at 760 mmHg
Vapour Pressure: 0.00284 mmHg at 25°C
3-Methyl-2-phenylmorpholine hydrochloride Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 50mg/kg (50mg/kg) | National Technical Information Service. Vol. AD277-689, | |
| mouse | LD50 | intravenous | 71mg/kg (71mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Toxicology and Applied Pharmacology. Vol. 2, Pg. 589, 1960. |
| mouse | LD50 | oral | 165mg/kg (165mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 711, 1963. |
| mouse | LD50 | subcutaneous | 240mg/kg (240mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: EXCITEMENT SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Acta Pharmaceutica Suecica. Vol. 4, Pg. 37, 1967. |
| rabbit | LD50 | intravenous | 41mg/kg (41mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 286, 1972. | |
| rat | LD50 | intraperitoneal | 175mg/kg (175mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Toxicology and Applied Pharmacology. Vol. 2, Pg. 589, 1960. |
| rat | LD50 | oral | 165mg/kg (165mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Arzneimittel-Forschung. Drug Research. Vol. 13, Pg. 711, 1963. |
| rat | LD50 | subcutaneous | 350mg/kg (350mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Toxicology and Applied Pharmacology. Vol. 2, Pg. 589, 1960. |
3-Methyl-2-phenylmorpholine hydrochloride Safety Profile
RIDADR: 3249
HazardClass: 6.1(b)
PackingGroup: III
Poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. Human reproductive effects. Human teratogenic effects by ingestion: developmental abnormalities of the respiratory and gastrointestinal systems, and effects on newborn including neonatal measures or effects. When heated to decomposition it emits very toxic fumes of NOx and HCl.
What can I do for you?
Get Best Price
